ACE hypertension treatment
dc.contributor.author | Ker, James A. | |
dc.date.accessioned | 2015-08-03T06:05:24Z | |
dc.date.available | 2015-08-03T06:05:24Z | |
dc.date.issued | 2015-04 | |
dc.description.abstract | Abundant evidence from randomised controlled trials has documented that antihypertensive drug treatment is of benefit in reducing cardiovascular (CV) events in people with hypertension. | en_ZA |
dc.description.librarian | am2015 | en_ZA |
dc.description.uri | http://media24business.com/specialist-forum-journal | en_ZA |
dc.identifier.citation | Ker, J 2015, 'ACE hypertension treatment', The Specialist Forum, vol. 15, no. 3, pp. 48. | en_ZA |
dc.identifier.issn | 2218-8282 | |
dc.identifier.uri | http://hdl.handle.net/2263/49221 | |
dc.language.iso | en | en_ZA |
dc.publisher | Media 24 | en_ZA |
dc.rights | Media 24 | en_ZA |
dc.subject | Hypertension | en_ZA |
dc.subject | Treatment | en_ZA |
dc.subject | Patient | en_ZA |
dc.subject | Cardiovascular (CV) | en_ZA |
dc.subject | Angiotensin converting enzyme inhibitors (ACE-I) | en_ZA |
dc.title | ACE hypertension treatment | en_ZA |
dc.type | Article | en_ZA |